Protective effects of S-nitrosoalbumin on lung injury induced by hypoxia-reoxygenation in mouse model of sickle cell disease

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 291, Issue 3, 2006, Pages

  De Franceschi, Lucia ^a   Malpeli, Giorgio ^a   Scarpa, Aldo ^a   Janin, Anne ^b   Muchitsch, Eva Maria ^c   Roncada, Paola ^d   Leboeuf, Christhope ^b   Corrocher, Roberto ^a   Beuzard, Yves ^b   Brugnara, Carlo ^e  

^a UNIVERSITY OF VERONA   (Italy)

^b SAINT LOUIS HOSPITAL   (France)

^c BAXTER BIOSCIENCE   (Austria)

^d Istituto Sperimentale Italiano Lazzaro Spallanzani   (Italy)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Hypoxic lung injury; Nitric oxide; Nitrite; Transgenic sickle cell SAD mice

Indexed keywords

ALBUMIN; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; NITRIC OXIDE DONOR; S NITROSOALBUMIN; UNCLASSIFIED DRUG;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; GENE EXPRESSION; HEMODYNAMICS; HYPOTENSION; HYPOXIA; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION; SICKLE CELL ANEMIA; THROMBOCYTE AGGREGATION; THROMBOGENESIS; TRANSGENIC MOUSE;

ANEMIA, SICKLE CELL; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANOXIA; DISEASE MODELS, ANIMAL; DRUG EVALUATION; FEMALE; HEMODYNAMIC PROCESSES; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; NITROSO COMPOUNDS; PLATELET AGGREGATION; PULMONARY VENO-OCCLUSIVE DISEASE; REPERFUSION INJURY; SERUM ALBUMIN, BOVINE;

EID: 33748416055     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00462.2005     Document Type: Article

References (44)

1. Atkinson JJ and Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 28: 12-24, 2003.
2. Bauer C, Kuntz W, Ohnsmann F, Gasser H, Weber C, Redl H, and Marzi I. The attenuation of hepatic microcirculatory alterations by exogenous substitution of nitric oxide by S-nitroso-human albumin after hemorrhagic shock in the rat. Shock 21: 165-169, 2004.
3. Belcher JD, Mahaseth H, Kalambur VS, Welch TE, Swanlund DJ, Ma L, Hsia CJ, Hebbel RP, Bischof JC, and Vercellotti GM. Microvascular blood flow in transgenic sickle mice: prevention of stasis with polynitroxylalbumin (Abstract). Proceedings of 28th Annual Meeting of the National Sickle Cell Disease Program (Cincinnati, OH), 2004, p. 19.
4. De Franceschi L, Baron A, Scarpa A, Adrie C, Janin A, Barbi S, Kister J, Rouyer-Fessard P, Corrocher R, Leboulch P, and Beuzard Y. Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation. Blood 102: 1087-1096, 2003.
5. De Franceschi L, Brugnara C, Rouyer-Fessard P, Jouault H, and Beuzard Y. Formation of dense erythrocytes in SAD mice exposed to chronic hypoxia: evaluation of different therapeutic regimens and of a combination of oral clotrimazole and magnesium therapies. Blood 94: 4307-4313, 1999.
6. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, Gladwin MT, and Lefer DJ. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 115: 1232-1240, 2005.
7. Dworschak M, Franz M, Hallstrom S, Semsroth S, Gasser H, Haisjackl M, Podesser BK, and Malinski T. S-nitroso human serum albumin improves oxygen metabolism during reperfusion after severe myocardial ischemia. Pharmacology 72: 106-112, 2004.
8. Fox-Robichaud A, Payne D, Hasan SU, Ostrovsky L, Fairhead T, Reinhardt P, and Kubes P. Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 101: 2497-2505, 1998.
9. Frostell C, Fratacci MD, Wain JC, Jones R, and Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038-2047, 1991.
10. Gluckman TL, Grossman JE, Folts JD, and Kruse-Elliott KT. Modulation of endotoxin-induced cardiopulmonary dysfunction by S-nitrosoalbumin. J Endotoxin Res 8: 17-26, 2002.
11. Hebbel RP. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest 100: S83-S86, 1997.
12. Lentsch AB, Kato A, Saari JT, and Schuschke DA. Augmented metalloproteinase activity and acute lung injury in copper-deficient rats. Am J Physiol Lung Cell Mol Physiol 281: L387-L393, 2001.
13. Mahaseth H, Belcher J, Welch TE, Sonbol KM, Bowlin PR, Hebbel RP, Ma L, Hsia CJC, and Vercellotti GM. Polynitroxyl albumin prevents vaso-occlusion in transgenic sickle mice (Abstract). Blood 104: 1082, 2004.
14. Mahaseth H, Vercellotti GM, Welch TE, Bowlin PR, Sonbol KM, Hsia CJ, Li M, Bischof JC, Hebbel RP, and Belcher JD. Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice. J Lab Clin Med 145: 204-211, 2005.
15. Martin J, Lutter G, Sarai K, Senn-Grossberger M, Takahashi N, Bitu-Moreno J, Haberstroh J, and Beyersdorf F. Investigations on the new free radical scavenger polynitroxyl-albumin to prevent ischemia and reperfusion injury after orthotopic heart transplantation in the pig model. Eur J Cardiothorac Surg 19: 321-325, 2001.
16. Meldrum DR, McIntyre RC, Sheridan BC, Cleveland JC Jr, Fullerton DA, and Harken AH. L-Arginine decreases alveolar macrophage proinflammatory monokine production during acute lung injury by a nitric oxide synthase-dependent mechanism. J Trauma 43: 888-893, 1997.
17. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, and Kadowitz PJ. Evidence for the inhibitory role of guanosine 3′,5′- monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57: 946-955, 1981.
18. Mittermayr R, Valentini D, Fitzal F, Hallstrom S, Gasser H, and Redl H. Protective effect of a novel NO-donor on ischemia/reperfusion injury in a rat epigastric flap model. Wound Repair Regen 11: 3-10, 2003.
19. Ng ES, Jourd'heuil D, McCord JM, Hernandez D, Yasui M, Knight D, and Kubes P. Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ Res 94: 559-565, 2004.
20. Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 3: 409-421, 2002.
21. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, and Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338: 1173-1174, 1991.
22. Platt OS. The acute chest syndrome of sickle cell disease. N Engl J Med 342: 1904-1907, 2000.
23. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, and Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330: 1639-1644, 1994.
24. Powers KA, Kapus A, Khadaroo RG, Papia G, and Rotstein OD. 25% Albumin modulates adhesive interactions between neutrophils and the endothelium following shock/resuscitation. Surgery 132: 391-398, 2002.
25. Qureshe MSP and Girgis R. Decreased exhaled nitric oxide (NO) in patients with sickle cell disease (Abstract). Blood 90: 2571, 2000.
26. Russell J, Okayama N, Alexander JS, Granger DN, and Hsia CJ. Pretreatment with polynitroxyl albumin (PNA) inhibits ischemia-reperfusion induced leukocyte-endothelial cell adhesion. Free Radic Biol Med 25: 153-159, 1998.
27. Shapiro SD and Senior RM. Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 20: 1100-1102, 1999.
28. Steinbauer M, Guba M, Buchner M, Farkas S, Anthuber M, and Jauch KW. Impact of polynitroxylated albumin (PNA) and tempol on ischemia/reperfusion injury: intravital microscopic study in the dorsal skinfold chamber of the Syrian golden hamster. Shock 14: 163-168, 2000.
29. Steinberg J, Halter J, Schiller HJ, Dasilva M, Landas S, Gatto LA, Maisi P, Sorsa T, Rajamaki M, Lee HM, and Nieman GF. Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. J Surg Res 111: 185-195, 2003.
30. Steinberg MH. Management of sickle cell disease. N Engl J Med 340: 1021-1030, 1999.
31. Sugawara T, Yu F, Ma L, Hsia CJ, and Chan PH. Delayed treatment with polynitroxyl albumin reduces infarct size after stroke in rats. Neuroreport 12: 3609-3612, 2001.
32. Trifilieff A, Walker C, Keller T, Kottirsch G, and Neumann U. Pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-α converting enzyme and matrix metalloproteinases, in models of airway inflammation. Br J Pharmacol 135: 1655-1664, 2002.
33. Trudel M, De Paepe ME, Chretien N, Saadane N, Jacmain J, Sorette M, Hoang T, and Beuzard Y. Sickle cell disease of transgenic SAD mice. Blood 84: 3189-3197, 1994.
34. Trudel M, Saadane N, Garel MC, Bardakdjian-Michau J, Blouquit Y, Guerquin-Kern JL, Rouyer-Fessard P, Vidaud D, Pachnis A, Romeo PH, Beuzard Y, and Constantini F. Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD. EMBO J 10: 3157-3165, 1991.
35. Tsikas D, Sandmann J, Luessen P, Savva A, Rossa S, Stichtenoth DO, and Frolich JC. S-transnitrosylation of albumin in human plasma and blood in vitro and in vivo in the rat. Biochim Biophys Acta 1546: 422-434, 2001.
36. Walley KR, McDonald TE, Higashimoto Y, and Hayashi S. Modulation of proinflammatory cytokines by nitric oxide in murine acute lung injury. Am J Respir Crit Care Med 160: 698-704, 1999.
37. Wang X, Tanus-Santos JE, Reiter CD, Dejam A, Shiva S, Smith RD, Hogg N, and Gladwin MT. Biological activity of nitric oxide in the plasmatic compartment. Proc Natl Acad Sci USA 101: 11477-11482, 2004.
38. Warnecke G, Struber M, Fraud S, Hohlfeld JM, and Haverich A. Combined exogenous surfactant and inhaled nitric oxide therapy for lung ischemia-reperfusion injury in minipigs. Transplantation 71: 1238-1244, 2001.
39. Warner RL, Lewis CS, Beltran L, Younkin EM, Varani J, and Johnson KJ. The role of metalloelastase in immune complex-induced acute lung injury. Am J Pathol 158: 2139-2144, 2001.
40. Watts JA and Maiorano PC. Trace amounts of albumin protect against ischemia and reperfusion injury in isolated rat hearts. J Mol Cell Cardiol 31: 1653-1662, 1999.
41. Webb A, Bond R, McLean P, Uppal R, Benjamin N, and Ahluwalia A. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci USA 101: 13683-13688, 2004.
42. Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, and Brugnara C. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA 289: 1136-1142, 2003.
43. Zhang H, Voglis S, Kim CH, and Slutsky AS. Effects of albumin and Ringer's lactate on production of lung cytokines and hydrogen peroxide after resuscitated hemorrhage and endotoxemia in rats. Crit Care Med 31: 1515-1522, 2003.
44. Zheng S, Zhang WY, Zhu LW, Lin K, and Sun B. Surfactant and inhaled nitric oxide in rats alleviate acute lung injury induced by intestinal ischemia and reperfusion. J Pediatr Surg 36: 980-984, 2001.